Zemplar (paricalcitol ) capsules
M05-741
Phase 2 small_molecule completed
Quick answer
Zemplar (paricalcitol ) capsules for Diabetic Nephropathy is a Phase 2 program (small_molecule) at Abbott Australasia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Abbott Australasia Pty Ltd
- Indication
- Diabetic Nephropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed